Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus

Qian,Yuan; Sun,Hao; Xiao,Hongli; Ma,Meirun; Xiao,Xue; Qu,Qinzai

doi:10.3892/br.2017.878

Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus

Authors:
- Yuan Qian
- Hao Sun
- Hongli Xiao
- Meirun Ma
- Xue Xiao
- Qinzai Qu
View Affiliations

Affiliations: Pre‑natal Diagnosis Laboratory, Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Kunming Medical College, Kunming, Yunnan 650032, P.R. China, Department of Human Genetics, Genetics Laboratory, The Institute of Medical Biology, Chinese Academy of Medical Science, Kunming, Yunnan 650032, P.R. China
Published online on: March 22, 2017 https://doi.org/10.3892/br.2017.878
Pages: 503-512
Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Increasing evidence has shown that insulin resistance in omental visceral adipose tissue (OVAT) is a characteristic of gestational diabetes mellitus (GDM). The present study aimed to identify differentially expressed genes (DEGs) and their associated functions and pathways involved in the pathogenesis of GDM by comparing the expression profiles of OVATs obtained from pregnant Chinese women with and without GDM during caesarian section. A total of 935 DEGs were identified, including 450 downregulated and 485 upregulated genes. In the gene ontology category cellular components, the DEGs were predominantly associated with functions of the extracellular region, while receptor binding was predominant in the molecular function category and biological process terms included antigen processing and presentation, extracellular matrix organization, positive regulation of cell‑substrate adhesion, response to nutrients and response to dietary excess. Functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were performed and a functional interaction network was constructed. Functions of downregulated genes included antigen processing and presentation as well as cell adhesion molecules, while those of upregulated genes included transforming growth factor (TGF)‑β‑signaling, focal adhesion, phosphoinositide‑3 kinase‑Akt‑signaling, P53 signaling, extracellular matrix‑receptor interaction and regulation of actin cytoskeleton pathway. The five main pathways associated with GDM were antigen processing and presentation, cell adhesion molecules, Type 1 diabetes mellitus, natural killer cell‑mediated cytotoxicity and TGF‑β signaling. These pathways were included in the KEGG pathway categories of ‘signaling molecules and interaction’, ‘immune system’ and ‘inflammatory response’, suggesting that these processes are involved in GDM. The results of the present study enhanced the present understanding of the mechanisms associated with insulin resistance in OVATs of GDM.

View Figures

View References

1	Kjos SL and Buchanan TA: Gestational diabetes mellitus. N Engl J Med. 341:1749–1756. 1999. View Article : Google Scholar : PubMed/NCBI
2	Kasuga M: Insulin resistance and pancreatic beta cell failure. J Clin Invest. 116:1756–1760. 2006. View Article : Google Scholar : PubMed/NCBI
3	White MF: Insulin signaling in health and disease. Science. 302:1710–1711. 2003. View Article : Google Scholar : PubMed/NCBI
4	Wójcik M, Chmielewska-Kassassir M, Grzywnowicz K, Woźniak L and Cypryk K: The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol Pol. 65:134–142. 2014. View Article : Google Scholar : PubMed/NCBI
5	Fasshauer M, Blüher M and Stumvoll M: Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2:488–499. 2014. View Article : Google Scholar : PubMed/NCBI
6	Ibrahim MM: Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev. 11:11–18. 2010. View Article : Google Scholar : PubMed/NCBI
7	Insenser M, Montes-Nieto R, Vilarrasa N, Lecube A, Simó R, Vendrell J and Escobar-Morreale HF: A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol. 363:10–19. 2012. View Article : Google Scholar : PubMed/NCBI
8	Sun G: Application of DNA microarrays in the study of human obesity and type 2 diabetes. OMICS. 11:25–40. 2007. View Article : Google Scholar : PubMed/NCBI
9	Draghici S, Khatri P, Eklund AC and Szallasi Z: Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. 22:101–109. 2006. View Article : Google Scholar : PubMed/NCBI
10	Allison DB, Cui X, Page GP and Sabripour M: Microarray data analysis: From disarray to consolidation and consensus. Nat Rev Genet. 7:55–65. 2006. View Article : Google Scholar : PubMed/NCBI
11	Guilherme A, Virbasius JV, Puri V and Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367–377. 2008. View Article : Google Scholar : PubMed/NCBI
12	Maassen JA, Romijn JA and Heine RJ: Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: A new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia. 50:2036–2041. 2007. View Article : Google Scholar : PubMed/NCBI
13	Ma Y, Gao J, Yin J, Gu L, Liu X, Chen S, Huang Q, Lu H, Yang Y, Zhou H, et al: Identification of a Novel Function of Adipocyte Plasma Membrane-Associated Protein (APMAP) in Gestational Diabetes Mellitus by Proteomic Analysis of Omental Adipose Tissue. J Proteome Res. 15:628–637. 2016. View Article : Google Scholar : PubMed/NCBI
14	Oliva K, Barker G, Rice GE, Bailey MJ and Lappas M: 2D-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue. J Endocrinol. 218:165–178. 2013. View Article : Google Scholar : PubMed/NCBI
15	Evangelou M, Smyth DJ, Fortune MD, Burren OS, Walker NM, Guo H, Onengut-Gumuscu S, Chen WM, Concannon P, Rich SS, et al: A method for gene-based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations. Genet Epidemiol. 38:661–670. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhou F, Huang X, Zhang Z, Chen Y, Liu X, Xing J and He X: Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer. Cancer Chemother Pharmacol. 75:1207–1215. 2015. View Article : Google Scholar : PubMed/NCBI
17	Wang L, Zhang Y, Lv W, Lu J, Mu J, Liu Y and Dong P: Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in GBC-SD/M and GBC-SD gallbladder cancer cell lines. Chem Biol Drug Des. 86:1064–1071. 2015. View Article : Google Scholar : PubMed/NCBI
18	Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, et al: Neuronal cell adhesion genes and antidepressant response in three independent samples. Pharmacogenomics J. 15:538–548. 2015. View Article : Google Scholar : PubMed/NCBI
19	Eves R, Oldham R, Jia L and Mak AS: The roles of akt isoforms in the regulation of podosome formation in fibroblasts and extracellular matrix invasion. Cancers (Basel). 7:96–111. 2015. View Article : Google Scholar : PubMed/NCBI
20	Phung TL, Du W, Xue Q, Ayyaswamy S, Gerald D, Antonello Z, Nhek S, Perruzzi CA, Acevedo I, Ramanna-Valmiki R, et al: Akt1 and akt3 exert opposing roles in the regulation of vascular tumor growth. Cancer Res. 75:40–50. 2015. View Article : Google Scholar : PubMed/NCBI
21	Waisberg J, De Souza Viana L, Affonso Junior RJ, Silva SR, Denadai MV, Margeotto FB, De Souza CS and Matos D: Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer. Anticancer Res. 34:5599–5607. 2014.PubMed/NCBI
22	Denadai MV, Viana LS, Affonso RJ Jr, Silva SR, Oliveira ID, Toledo SR and Matos D: Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma. BMC Clin Pathol. 13:162013. View Article : Google Scholar : PubMed/NCBI
23	Hosen I, Rachakonda PS, Heidenreich B, de Verdier PJ, Ryk C, Steineck G, Hemminki K and Kumar R: Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. Int J Cancer. 137:1621–1629. 2015. View Article : Google Scholar : PubMed/NCBI
24	Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, Schutz FA, Park RS, O'Brien RJ, Hirsch MS, et al: FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med. 3:835–844. 2014. View Article : Google Scholar : PubMed/NCBI
25	Noctor E, Crowe C, Carmody LA, Kirwan B, O'Dea A, Glynn LG, McGuire BE, O'Shea PM and Dunne FP: ATLANTIC-DIP: Prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol. 52:153–160. 2015. View Article : Google Scholar : PubMed/NCBI
26	Koning SH, Hoogenberg K, Scheuneman KA, Baas MG, Korteweg FJ, Sollie KM, Schering BJ, van Loon AJ, Wolffenbuttel BH, van den Berg PP, et al: Neonatal and obstetric outcomes in diet- and insulin-treated women with gestational diabetes mellitus: A retrospective study. BMC Endocr Disord. 16:522016. View Article : Google Scholar : PubMed/NCBI
27	Zhao YH, Wang DP, Zhang LL, Zhang F, Wang DM and Zhang WY: Genomic expression profiles of blood and placenta reveal significant immune-related pathways and categories in Chinese women with gestational diabetes mellitus. Diabet Med. 28:237–246. 2011. View Article : Google Scholar : PubMed/NCBI
28	Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R and Seki E: Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 59:483–495. 2014. View Article : Google Scholar : PubMed/NCBI
29	Mauricio D and de Leiva A: Autoimmune gestational diabetes mellitus: A distinct clinical entity? Diabetes Metab Res Rev. 17:422–428. 2001. View Article : Google Scholar : PubMed/NCBI
30	Evangelista AF, Collares CV, Xavier DJ, Macedo C, Manoel-Caetano FS, Rassi DM, Foss-Freitas MC, Foss MC, Sakamoto-Hojo ET, Nguyen C, et al: Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammation. BMC Med Genomics. 7:282014. View Article : Google Scholar : PubMed/NCBI
31	Binder AM, LaRocca J, Lesseur C, Marsit CJ and Michels KB: Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex. Clin Epigenetics. 7:792015. View Article : Google Scholar : PubMed/NCBI
32	Steinborn A, Saran G, Schneider A, Fersis N, Sohn C and Schmitt E: The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol. 56:124–134. 2006. View Article : Google Scholar : PubMed/NCBI
33	Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, McKee C, Soeda J, Fernandez-Twinn DS, Martin-Gronert MS, Ozanne SE, et al: Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol. 52:913–920. 2010. View Article : Google Scholar : PubMed/NCBI
34	Dotta F, Fondelli C and Falorni A: Can NK cells be a therapeutic target in human type 1 diabetes? Eur J Immunol. 38:2961–2963. 2008. View Article : Google Scholar : PubMed/NCBI
35	Hauguel-de Mouzon S and Guerre-Millo M: The placenta cytokine network and inflammatory signals. Placenta. 27:794–798. 2006. View Article : Google Scholar : PubMed/NCBI
36	Lee BC and Lee J: Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 1842:446–462. 2014. View Article : Google Scholar : PubMed/NCBI
37	Lumeng CN and Saltiel AR: Inflammatory links between obesity and metabolic disease. J Clin Invest. 121:2111–2117. 2011. View Article : Google Scholar : PubMed/NCBI
38	Hursting SD and Dunlap SM: Obesity, metabolic dysregulation, and cancer: A growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci. 1271:82–87. 2012. View Article : Google Scholar : PubMed/NCBI
39	Balsan GA, Vieira JL, Oliveira AM and Portal VL: Relationship between adiponectin, obesity and insulin resistance. Rev Assoc Med Bras 1992. 61:72–80. 2015. View Article : Google Scholar : PubMed/NCBI
40	Lebrun P, Baron V, Hauck CR, Schlaepfer DD and Van Obberghen E: Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression. J Biol Chem. 275:38371–38377. 2000. View Article : Google Scholar : PubMed/NCBI
41	Gupta A and Dey CS: PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance. Mol Biol Cell. 23:3882–3898. 2012. View Article : Google Scholar : PubMed/NCBI
42	Gupta A, Bisht B and Dey CS: Focal adhesion kinase negatively regulates neuronal insulin resistance. Biochim Biophys Acta. 1822:1030–1037. 2012. View Article : Google Scholar : PubMed/NCBI
43	Bisht B and Dey CS: Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells. BMC Cell Biol. 9:482008. View Article : Google Scholar : PubMed/NCBI
44	Zhang L, Cui Y, Fu F, Li Z, Pan X, Li H and Li L: An insight into the key genes and biological functions associated with insulin resistance in adipose tissue with microarray technology. Mol Med Rep. 11:1963–1967. 2015.PubMed/NCBI